Chen Yisong, Hua Keqin
Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China.
Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Int J Gynaecol Obstet. 2017 May;137(2):164-169. doi: 10.1002/ijgo.12097. Epub 2017 Feb 17.
To compare laparoscopic sacrocolpopexy (LSC) or sacrohysteropexy (LSH) with vaginal sacrospinous ligament fixation (VSSLF) for middle compartment pelvic organ prolapse (POP).
Data were retrospectively reviewed from patients with POP (stage 3 or worse) who underwent LSC, LSH, or VSSLF at a center in Shanghai between January 2009 and March 2014. POP quantification (POP-Q) and Pelvic Floor Distress Inventory scores were compared at the 2-year follow-up.
Data were available for the 2-year follow-up for 102 LSC, 11 LSH, and 94 VSSLF procedures. Compared with patients who had undergone VSSLF, those who had undergone LSC/LSH had better POP-Q C values (P<0.001), longer total vaginal length (TVL) (P<0.001), and lower Aa and Ba scores (P=0.003 and P=0.002, respectively). Apical compartment and overall success rates of LSC/LSH and VSSLF did not differ significantly. Quality of life was improved in both groups (P<0.001). Both groups achieved symptomatic relief, although bowel and urinary functions were significantly improved only in the VSSLF group (P<0.001 for both). More patients in the LSC/LSH group were sexually active at 2 years (P<0.001); improvement in sex life was similar between the groups.
Although LSC/LSH achieved longer TVL, both groups achieved the same success rate and improvement in quality of life. Specifically, VSSLF yielded a significant improvement in bowel and urinary function.
比较腹腔镜骶骨阴道固定术(LSC)或骶骨子宫固定术(LSH)与阴道骶棘韧带固定术(VSSLF)治疗中盆腔器官脱垂(POP)的效果。
回顾性分析2009年1月至2014年3月在上海某中心接受LSC、LSH或VSSLF治疗的POP患者(3期及以上)的数据。比较2年随访时的POP量化(POP-Q)和盆底困扰量表评分。
102例LSC、11例LSH和94例VSSLF手术有2年随访数据。与接受VSSLF的患者相比,接受LSC/LSH的患者有更好的POP-Q C值(P<0.001)、更长的阴道总长度(TVL)(P<0.001)以及更低的Aa和Ba评分(分别为P=0.003和P=0.002)。LSC/LSH和VSSLF的顶端盆腔和总体成功率无显著差异。两组患者的生活质量均得到改善(P<0.001)。两组均实现了症状缓解,尽管仅VSSLF组的肠道和泌尿功能有显著改善(两者均为P<0.001)。LSC/LSH组更多患者在2年时有性生活(P<0.001);两组性生活改善情况相似。
尽管LSC/LSH实现了更长的TVL,但两组的成功率和生活质量改善情况相同。具体而言,VSSLF在肠道和泌尿功能方面有显著改善。